市場調查報告書
商品編碼
1347608
醫用泡沫市場:2023-2028 年全球行業趨勢、佔有率、規模、成長、機遇和預測Medical Foam Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球醫用泡沫市場規模達到291億美元。展望未來,IMARC Group預計到2028年市場規模將達到427億美元,2023-2028年年複合成長率(CAGR)為6.4%。
醫用泡沫是指用於多種醫療設備、組件和支撐材料的抗菌產品,例如醫療行業的手術單、傷口敷料和床上用品。它採用多孔聚氨酯、聚合物和金屬製造。醫用泡沫還廣泛用於假肢襯墊、客製化矯形器、密封造口設備和身體足底壓力釋放設備。它具有多種特性,例如防水、抗張、抗真菌、柔軟、耐用、無菌和多功能性,因此適合保護性包裝用途。醫用泡沫具有緩解壓力的功能,可適應患者的體形,有助於提供舒適、放鬆和緩解壓力緩解點。目前,它有剛性、軟性和模製產品類型。
全球老年人口不斷增加,更容易患各種慢性病,這是推動市場成長的關鍵因素之一。醫用泡沫在大手術後的患者康復過程中發揮著至關重要的作用,因為它們廣泛用於床上用品和緩衝產品以提高舒適度。此外,醫用泡沫由於其優異的抗壓縮形變性、衝擊吸收性和多功能性等多種特性,在醫療系統緩沖和傷口敷料等眾多應用中的使用不斷增加,有利於市場成長。除此之外,冠狀病毒病(COVID-19)和豬流感等流行病爆發病例的增加,以及人們對個人衛生相關健康問題的日益關注,都為市場成長提供了動力。此外,醫療呼吸和麻醉系統和設備中對熱濕交換(HME)泡沫的需求不斷成長,這些泡沫可提供一致和受控的氧氣和氣體攝入,同時確保無菌條件,這對市場成長產生了積極影響。其他因素,包括醫療行業的大幅擴張、對植入式醫療設備的需求不斷增加以及從傳統傷口護理產品向先進傷口護理產品的轉變,預計將推動市場成長。
The global medical foam market size reached US$ 29.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 42.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028.
Medical foam refers to an antimicrobial product used in numerous medical devices, components, and support materials, such as surgical drapes, wound dressing, and bedding materials in the healthcare industry. It is manufactured using cell polyurethane, polymers and metals. Medical foam is also widely used in prosthetic padding, custom orthotics, sealing ostomy equipment and body underfoot pressure relief equipment. It exhibits various properties, such as water, strain and fungal resistance, softness, durability, sterility, and versatility, thus making it suitable for protective packaging purposes. Medical foams offer compression relieving capabilities that adapt to the patient's body shape and assist in providing comfort, relaxation and alleviating pressure relief points. Currently, it is available in rigid, flexible, and molded product types.
The rising geriatric population across the globe that are more prone to developing various chronic ailments represents one of the key factors driving the growth of the market. Medical foam plays a vital role during patient recovery post major surgeries as they are widely used in bedding and cushioning products to enhance comfort. Additionally, the increasing usage of medical foam in numerous applications, such as medical system cushioning and wound dressings, due to its various properties, such as excellent compression-set resistance, impact-absorbing and versatility, is favoring the market growth. Apart from this, increasing cases of epidemic outbreaks, such as coronavirus disease (COVID-19) and swine flu, along with rising health concerns among people related to personal hygiene, are providing an impetus to the market growth. Moreover, the increasing demand for heat and moisture exchange (HME) foams in medical breathing and anesthesia systems and equipment that provide a consistent and controlled oxygen and gas intake, while also ensuring sterile conditions are positively impacting the market growth. Other factors, including the significant expansion in the medical industry, increasing demand for implantable medical devices, and the shifting inclination from traditional to advanced wound care products are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical foam market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, material and application.
Rigid
Flexible
Molded
Polymers
Metals
Other
Bedding and Cushioning
Medical Packaging
Medical Devices and Components
Prosthetics and Wound Care
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Medical Solutions Group Plc, BASF SE, Draka Interfoam B.V., Foamtec Medical, Freudenberg Performance Materials, FXI, General Plastics Manufacturing Company Inc., Global Medical Foam Inc., Inoac Corporation, Recticel NV, Rogers Corporation, SEKISUI CHEMICAL CO. LTD. and Ufp Technologies Inc.